The estimated annual global burden of melioidosis is approximately 165,000 cases, including 89,000 deaths. It occurs in people of all ages, but the peak incidence is in adults aged 40-60 years. It accounts for 4.6 million disability-adjusted life years globally (or 84 per 100,000 population).
BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.
To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.
You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.
Use of this content is subject to our disclaimer